{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HIV", "anti-HIV agents", "natural products", "neurocognitive disorders"]], "OtherID": [], "CitationSubset": [], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26793166", "DateCompleted": {"Year": "2016", "Month": "01", "Day": "21"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "01", "Day": "12"}], "ELocationID": ["1444", "10.3389/fmicb.2015.01444"], "Language": ["eng"], "Journal": {"ISSN": "1664-302X", "JournalIssue": {"Volume": "6", "PubDate": {"Year": "2015"}}, "Title": "Frontiers in microbiology", "ISOAbbreviation": "Front Microbiol"}, "ArticleTitle": "Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview.", "Pagination": {"StartPage": "1444", "MedlinePgn": "1444"}, "Abstract": {"AbstractText": ["As the threat of Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) persists to rise, effective drug treatments are required to treat the infected people. Even though combination antiretroviral therapy (cART) provides stable viral suppression, it is not devoid of undesirable side effects, especially in persons undergoing long-term treatment. The present therapy finds its limitations in the emergence of multidrug resistance and accordingly finding new drugs and novel targets is the need of the hour to treat the infected persons and further to attack HIV reservoirs in the body like brain, lymph nodes to achieve the ultimate goal of complete eradication of HIV and AIDS. Natural products such as plant-originated compounds and plant extracts have enormous potential to become drug leads with anti-HIV and neuroprotective activity. Accordingly, many research groups are exploring the biodiversity of the plant kingdom to find new and better anti-HIV drugs with novel mechanisms of action and for HIV-associated neurocognitive disorders (HAND). The basic challenge that still persists is to develop viral replication-targeted therapy using novel anti-HIV compounds with new mode of action, accepted toxicity and less resistance profile. Against this backdrop, the World Health Organization (WHO) suggested the need to evaluate ethno-medicines for the management of HIV/AIDS. Consequently, there is need to evaluate traditional medicine, particularly medicinal plants and other natural products that may yield effective and affordable therapeutic agents. Although there are a good number of reports on traditional uses of plants to treat various diseases, knowledge of herbal remedies used to manage HIV/AIDS and HAND are scanty, vague and not well documented. In this review, plant substances showing a promising action that is anti-HIV and HAND will be explored along with what they interact. Since some plant substances are also known to modulate several cellular factors which are also involved in the replication of HIV and hence their role as potential candidates will be discussed. HIV/AIDS being an exceptional epidemic, demands an exceptional approach and that forms very much focus for the current review."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami FL, USA."}], "LastName": "Kurapati", "ForeName": "Kesava Rao V", "Initials": "KR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami FL, USA."}], "LastName": "Atluri", "ForeName": "Venkata S", "Initials": "VS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami FL, USA."}], "LastName": "Samikkannu", "ForeName": "Thangavel", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami FL, USA."}], "LastName": "Garcia", "ForeName": "Gabriella", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami FL, USA."}], "LastName": "Nair", "ForeName": "Madhavan P N", "Initials": "MP"}], "GrantList": [{"GrantID": "R01 DA021537", "Acronym": "DA", "Agency": "NIDA NIH HHS", "Country": "United States"}, {"GrantID": "R01 DA027049", "Acronym": "DA", "Agency": "NIDA NIH HHS", "Country": "United States"}, {"GrantID": "R01 MH085259", "Acronym": "MH", "Agency": "NIMH NIH HHS", "Country": "United States"}, {"GrantID": "R37 DA025576", "Acronym": "DA", "Agency": "NIDA NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Microbiol", "NlmUniqueID": "101548977", "ISSNLinking": "1664-302X"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abd-Elazem I. S., Chen H. S., Bates R. B., Huang R. C. (2002). Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase from Salvia miltiorrhiza. Antiviral Res. 55 91\u2013106. 10.1016/S0166-3542(02)00011-6", "ArticleIdList": ["10.1016/S0166-3542(02)00011-6", "12076754"]}, {"Citation": "Achim C. L., Wiley C. A. (1996). Inflammation in AIDS and the role of the macrophage in brain pathology. Curr. Opin. Neurol. 9 221\u2013225. 10.1097/00019052-199606000-00013", "ArticleIdList": ["10.1097/00019052-199606000-00013", "8839616"]}, {"Citation": "Ahn M.-J., Kim C. Y., Lee J. S., Kim T. G., Kim S. H., Lee C.-K., et al. (2002). Inhibition of HIV-1 integrase by galloyl glucoses from terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis. Planta Med. 68 457\u2013459. 10.1055/s-2002-32070", "ArticleIdList": ["10.1055/s-2002-32070", "12058327"]}, {"Citation": "An P., Bleiber G., Duggal P., Nelson G., May M., Mangeat B., et al. (2004). APOBEC3G genetic variants and their influence on the progression to AIDS. J. Virol. 78 11070\u201311076. 10.1128/jvi.78.20.11070-11076.2004", "ArticleIdList": ["10.1128/jvi.78.20.11070-11076.2004", "PMC521814", "15452227"]}, {"Citation": "Anthony I., Ramage S., Carnie F., Simmonds P., Bell J. (2006). Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol. 111 529\u2013538. 10.1007/s00401-006-0037-0", "ArticleIdList": ["10.1007/s00401-006-0037-0", "16718349"]}, {"Citation": "Anthony I. C., Bell J. E. (2008). The neuropathology of HIV/AIDS. Int. Rev. Psychiatry 20 15\u201324. 10.1080/09540260701862037", "ArticleIdList": ["10.1080/09540260701862037", "18240059"]}, {"Citation": "Antinori A., Arendt G., Becker J. T., Brew B. J., Byrd D. A., Cherner M., et al. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69 1789\u20131799. 10.1212/01.WNL.0000287431.88658.8b", "ArticleIdList": ["10.1212/01.WNL.0000287431.88658.8b", "PMC4472366", "17914061"]}, {"Citation": "Appay V., Almeida J. R., Sauce D., Autran B., Papagno L. (2007). Accelerated immune senescence and HIV-1 infection. Exp. Gerontol. 42 432\u2013437. 10.1016/j.exger.2006.12.003", "ArticleIdList": ["10.1016/j.exger.2006.12.003", "17307327"]}, {"Citation": "Asres K., Bucar F., Kartnig T., Witvrouw M., Pannecouque C., De Clercq E. (2001). Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plants. Phytother. Res. 15 62\u201369. 10.1002/1099-1573(200102)15:1<62::AID-PTR956>3.0.CO;2-X", "ArticleIdList": ["10.1002/1099-1573(200102)15:1<62::AID-PTR956>3.0.CO;2-X", "11180526"]}, {"Citation": "Atluri V. S., Hidalgo M., Samikkannu T., Kurapati K. R., Jayant R. D., Sagar V., et al. (2015). Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update. Front. Cell Neurosci. 9:212 10.3389/fncel.2015.00212", "ArticleIdList": ["10.3389/fncel.2015.00212", "PMC4461820", "26113810"]}, {"Citation": "Atluri V. S., Pilakka-Kanthikeel S., Samikkannu T., Sagar V., Kurapati K. R., Saxena S. K., et al. (2014). Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder. Mol. Brain 7:37 10.1186/1756-6606-7-37", "ArticleIdList": ["10.1186/1756-6606-7-37", "PMC4040511", "24886748"]}, {"Citation": "Balzarini J. (1994). Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives. Pharm. World Sci. 16 113\u2013126. 10.1007/BF01880662", "ArticleIdList": ["10.1007/BF01880662", "8032337"]}, {"Citation": "Benito J. M., Lopez M., Soriano V. (2004). The role of CD8+ T-cell response in HIV infection. AIDS Rev. 6 79\u201388.", "ArticleIdList": ["15332430"]}, {"Citation": "Beutler J. A., Cardellina J. H., Mcmahon J. B., Boyd M. R., Cragg G. M. (1992). Anti-HIV and cytotoxic alkaloids from Buchenavia capitata. J. Nat. Prod. 55 207\u2013213. 10.1021/np50080a008", "ArticleIdList": ["10.1021/np50080a008", "1624941"]}, {"Citation": "Brandt J., Butters N., Ryan C., Bayog R. (1983). Cognitive loss and recovery in long-term alcohol abusers. Arch. Gen. Psychiatry 40 435\u2013442. 10.1001/archpsyc.1983.01790040089012", "ArticleIdList": ["10.1001/archpsyc.1983.01790040089012", "6838323"]}, {"Citation": "Broder S. (2009). The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Res. 85 1\u201318. 10.1016/j.antiviral.2009.10.002", "ArticleIdList": ["10.1016/j.antiviral.2009.10.002", "PMC2815149", "20018391"]}, {"Citation": "Buonaguro L., Tornesello M. L., Buonaguro F. M. (2007). Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications. J. Virol. 81 10209\u201310219. 10.1128/JVI.00872-07", "ArticleIdList": ["10.1128/JVI.00872-07", "PMC2045484", "17634242"]}, {"Citation": "Chan D. C., Kim P. S. (1998). HIV entry and its inhibition. Cell 93 681\u2013684. 10.1016/S0092-8674(00)81430-0", "ArticleIdList": ["10.1016/S0092-8674(00)81430-0", "9630213"]}, {"Citation": "Chang L., Ernst T., Witt M. D., Ames N., Gaiefsky M., Miller E. (2002). Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-Na\u00efve HIV patients. NeuroImage 17 1638\u20131648. 10.1006/nimg.2002.1254", "ArticleIdList": ["10.1006/nimg.2002.1254", "12414302"]}, {"Citation": "Charlton J. L. (1998). Antiviral activity of lignans. J. Nat. Prod. 61 1447\u20131451. 10.1021/np980136znp980136z", "ArticleIdList": ["10.1021/np980136znp980136z", "9834179"]}, {"Citation": "Chen D.-F., Zhang S.-X., Wang H.-K., Zhang S.-Y., Sun Q.-Z., Cosentino L. M., et al. (1999). Novel anti-HIV lancilactone C and related triterpenes from Kadsura lancilimba. J. Nat. Prod. 62 94\u201397. 10.1021/np980291d", "ArticleIdList": ["10.1021/np980291d", "9917290"]}, {"Citation": "Chen D. F., Zhang S. X., Xie L., Xie J. X., Chen K., Kashiwada Y., et al. (1997). Anti-AIDS agents\u2013XXVI. Structure-activity correlations of gomisin-G-related anti-HIV lignans from Kadsura interior and of related synthetic analogues. Bioorg. Med. Chem. 5 1715\u20131723. 10.1016/S0968-0896(97)00118-1", "ArticleIdList": ["10.1016/S0968-0896(97)00118-1", "9313872"]}, {"Citation": "Chinsembu K., Hedimbi M. (2010). Ethnomedicinal plants and other natural products with anti-HIV active compounds and their putative modes of action. Int. J. Biotechnol. Mol. Biol. Res. 1 74\u201391."}, {"Citation": "Clerici M., Balotta C., Salvaggio A., Riva C., Trabattoni D., Papagno L., et al. (1996). Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 88 574\u2013579.", "ArticleIdList": ["8695805"]}, {"Citation": "Cohen J. (2012). The many states of HIV in America. Science 337 168\u2013171. 10.1126/science.337.6091.168", "ArticleIdList": ["10.1126/science.337.6091.168", "22798593"]}, {"Citation": "Creagh T., Ruckle J. L., Tolbert D. T., Giltner J., Eiznhamer D. A., Dutta B.et al. (2001). Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects. Antimicrob. Agents Chemother. 45 1379\u20131386. 10.1128/AAC.45.5.1379-1386.2001", "ArticleIdList": ["10.1128/AAC.45.5.1379-1386.2001", "PMC90477", "11302799"]}, {"Citation": "Darbinian-Sarkissian N., Darbinyan A., Otte J., Radhakrishnan S., Sawaya B. E., Arzumanyan A., et al. (2006). p27(SJ), a novel protein in St John\u2019s Wort, that suppresses expression of HIV-1 genome. Gene Ther. 13 288\u2013295. 10.1038/sj.gt.3302649", "ArticleIdList": ["10.1038/sj.gt.3302649", "16251997"]}, {"Citation": "Darke S., Sims J., Mcdonald S., Wickes W. (2000). Cognitive impairment among methadone maintenance patients. Addiction 95 687\u2013695. 10.1046/j.1360-0443.2000.9556874.x", "ArticleIdList": ["10.1046/j.1360-0443.2000.9556874.x", "10885043"]}, {"Citation": "De Clercq E. (1995). Antiviral therapy for human immunodeficiency virus infections. Clin. Microbiol. Rev. 8 200\u2013239.", "ArticleIdList": ["PMC172856", "7542558"]}, {"Citation": "Decosterd L. A., Parsons I. C., Gustafson K. R., Cardellina J. H., Mcmahon J. B., Cragg G. M., et al. (1993). HIV inhibitory natural products. 11. Structure, absolute stereochemistry, and synthesis of conocurvone, a potent, novel HIV-inhibitory naphthoquinone trimer from a Conospermum sp. J. Am. Chem. Soc. 115 6673\u20136679. 10.1021/ja00068a026", "ArticleIdList": ["10.1021/ja00068a026"]}, {"Citation": "de Oliveira T., Pillay D., Gifford R. J., UK Collaborative Group on Hiv Drug Resistance (2010). The HIV-1 subtype c epidemic in South America is linked to the United Kingdom. PLoS ONE 5:e9311 10.1371/journal.pone.0009311", "ArticleIdList": ["10.1371/journal.pone.0009311", "PMC2824804", "20174561"]}, {"Citation": "Devlin K. N., Gongvatana A., Clark U. S., Chasman J. D., Westbrook M. L., Tashima K. T., et al. (2012). Neurocognitive effects of HIV, hepatitis C, and substance use history. J. Int. Neuropsychol. Soc. 18 68\u201378. 10.1017/s1355617711001408", "ArticleIdList": ["10.1017/s1355617711001408", "PMC4031745", "22132928"]}, {"Citation": "Dharmaratne H. R. W., Tan G. T., Marasinghe G. P. K., Pezzuto J. M. (2002). Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and Xanthones. Planta Med. 68 86\u201387. 10.1055/s-2002-20058", "ArticleIdList": ["10.1055/s-2002-20058", "11842340"]}, {"Citation": "Dhillon N., Williams R., Peng F., Tsai Y.-J., Dhillon S., Nicolay B., et al. (2007). Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia. J. Neurovirol. 13 483\u2013495. 10.1080/13550280701528684", "ArticleIdList": ["10.1080/13550280701528684", "18097880"]}, {"Citation": "Duan H., Takaishi Y., Imakura Y., Jia Y., Li D., Cosentino L. M., et al. (2000). Sesquiterpene alkaloids from Tripterygium hypoglaucum and Tripterygium wilfordii: a new class of potent Anti-HIV agents. J. Nat. Prod. 63 357\u2013361. 10.1021/np990281s", "ArticleIdList": ["10.1021/np990281s", "10757718"]}, {"Citation": "Ellis R. J., Badiee J., Vaida F., Letendre S., Heaton R. K., Clifford D., et al. (2011). CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS 25 1747\u20131751.", "ArticleIdList": ["PMC3867631", "21750419"]}, {"Citation": "El-Mekkawy S., Meselhy M. R., Nakamura N., Hattori M., Kawahata T., Otake T. (2000). Anti-HIV-1 phorbol esters from the seeds of Croton tiglium. Phytochemistry 53 457\u2013464. 10.1016/S0031-9422(99)00556-7", "ArticleIdList": ["10.1016/S0031-9422(99)00556-7", "10731023"]}, {"Citation": "Esiri M. M., Biddolph S. C., Morris C. S. (1998). Prevalence of alzheimer plaques in AIDS. J. Neurol. Neurosurg. Psychiatry 65 29\u201333. 10.1136/jnnp.65.1.29", "ArticleIdList": ["10.1136/jnnp.65.1.29", "PMC2170157", "9667557"]}, {"Citation": "Ettenhofer M. L., Hinkin C. H., Castellon S. A., Durvasula R., Ullman J., Lam M., et al. (2009). Aging, neurocognition, and medication adherence in HIV infection. Am. J. Geriatr. Psychiatry 17 281\u2013290. 10.1097/JGP.0b013e31819431bd00019442-200904000-00004", "ArticleIdList": ["10.1097/JGP.0b013e31819431bd00019442-200904000-00004", "PMC2679810", "19307857"]}, {"Citation": "Fabricant D. S., Farnsworth N. R. (2001). The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect. 109 69\u201375. 10.2307/3434847", "ArticleIdList": ["10.2307/3434847", "PMC1240543", "11250806"]}, {"Citation": "Farnsworth N. R. (2007). \u201cEthnopharmacology and drug development,\u201d in Ciba Foundation Symposium 185 \u2013 Ethnobotany and the Search for New Drugs eds Chadwick D. J., Marsh J. (Hoboken, NJ: John Wiley & Sons, Ltd; ) 42\u201359.", "ArticleIdList": ["7736861"]}, {"Citation": "Fuller R. W., Westergaard C. K., Collins J. W., Cardellina J. H., Boyd M. R. (1999). Vismiaphenones D\u2013G, new prenylated benzophenones from Vismia cayennensis. J. Nat. Prod. 62 67\u201369. 10.1021/np980152w", "ArticleIdList": ["10.1021/np980152w", "9917284"]}, {"Citation": "Fundacio Lluita Contra la SIDA (2011). Clinicaltrials.gov, \u2018Drug Interactions Between Echinacea Purpurea and Etravirine.\u2019 Available at: Clinicaltrials.gov [accessed December 1, 2015]."}, {"Citation": "Futterman D. (2012). HIV/AIDS: the next generation. Science 337:799 10.1126/science.337.6096.799-a", "ArticleIdList": ["10.1126/science.337.6096.799-a", "22903996"]}, {"Citation": "Gandhi N., Saiyed Z., Napuri J., Samikkannu T., Reddy P. B., Agudelo M., et al. (2010). Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder. J. Neurovirol. 16 294\u2013305. 10.3109/13550284.2010.499891", "ArticleIdList": ["10.3109/13550284.2010.499891", "20624003"]}, {"Citation": "Gandhi N., Saiyed Z., Thangavel S., Rodriguez J., Rao K. V. K., Nair M. P. N. (2009). Differential effects of HIV type 1 clade B and clade C tat protein on expression of proinflammatory and antiinflammatory cytokines by primary monocytes. AIDS Res. Hum. Retrovir. 25 691\u2013699. 10.1089/aid.2008.0299", "ArticleIdList": ["10.1089/aid.2008.0299", "PMC2853861", "19621989"]}, {"Citation": "Gannon P., Khan M. Z., Kolson D. L. (2013). Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr. Opin. Neurol. 24 275\u2013283. 10.1097/WCO.0b013e32834695fb", "ArticleIdList": ["10.1097/WCO.0b013e32834695fb", "PMC3683661", "21467932"]}, {"Citation": "Giunta B., Ehrhart J., Obregon D. F., Lam L., Le L., Jin J., et al. (2011). Antiretroviral medications disrupt microglial phagocytosis of \u03b2-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders. Mol. Brain 4 23\u201323. 10.1186/1756-6606-4-23", "ArticleIdList": ["10.1186/1756-6606-4-23", "PMC3128056", "21649911"]}, {"Citation": "Gonzalez R., Heaton R. K., Moore D. J., Letendre S., Ellis R. J., Wolfson T., et al. (2003). Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. J. Int. Neuropsychol. Soc. 9 64\u201371. 10.1017/S1355617703910071", "ArticleIdList": ["10.1017/S1355617703910071", "12570359"]}, {"Citation": "Gonzalez-Scarano F., Martin-Garcia J. (2005). The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5 69\u201381. 10.1038/nri1527", "ArticleIdList": ["10.1038/nri1527", "15630430"]}, {"Citation": "Green D. A., Masliah E., Vinters H. V., Beizai P., Moore D. J., Achim C. L. (2005). Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19 407\u2013411. 10.1097/01.aids.0000161770.06158.5c", "ArticleIdList": ["10.1097/01.aids.0000161770.06158.5c", "15750394"]}, {"Citation": "Grovit-Ferbas K., Harris-White M. E. (2010). Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction. Immunol. Res. 48 40\u201358. 10.1007/s12026-010-8166-x", "ArticleIdList": ["10.1007/s12026-010-8166-x", "20725864"]}, {"Citation": "Groweiss A., Cardellina J. H., Boyd M. R. (2000). HIV-Inhibitory prenylated Xanthones and flavones from Maclura tinctoria. J. Nat. Prod. 63 1537\u20131539. 10.1021/np000175m", "ArticleIdList": ["10.1021/np000175m", "11087602"]}, {"Citation": "Gustafson K. R., Cardellina J. H., Mcmahon J. B., Pannell L. K., Cragg G. M., Boyd M. R. (1992). HIV inhibitory natural products. 6. The peltatols, novel HIV-inhibitory catechol derivatives from Pothomorphe peltata. J. Organ. Chem. 57 2809\u20132811. 10.1021/jo00036a010", "ArticleIdList": ["10.1021/jo00036a010"]}, {"Citation": "Heaton R. K., Clifford D. B., Franklin D.R., Jr., Woods S. P., Ake C., Vaida F., et al. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75 2087\u20132096. 10.1212/WNL.0b013e318200d727", "ArticleIdList": ["10.1212/WNL.0b013e318200d727", "PMC2995535", "21135382"]}, {"Citation": "Heaton R. K., Franklin D. R., Ellis R. J., Mccutchan J. A., Letendre S. L., Leblanc S., et al. (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J. Neurovirol. 17 3\u201316. 10.1007/s13365-010-0006-1", "ArticleIdList": ["10.1007/s13365-010-0006-1", "PMC3032197", "21174240"]}, {"Citation": "Hedimbi M., Chinsembu K. C. (2012). Ethnomedicinal study of plants used to manage HIV/AIDS-related disease conditions in the Ohangwena region, Namibia. Int. J. Med. Plants Res. 1 4\u201311."}, {"Citation": "Hemelaar J. (2012). The origin and diversity of the HIV-1 pandemic. Trends Mol. Med. 18 182\u2013192. 10.1016/j.molmed.2011.12.001", "ArticleIdList": ["10.1016/j.molmed.2011.12.001", "22240486"]}, {"Citation": "Hemelaar J., Gouws E., Ghys P. D., Osmanov S. (2011). Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 25 679\u2013689. 10.1097/QAD.0b013e328342ff93", "ArticleIdList": ["10.1097/QAD.0b013e328342ff93", "PMC3755761", "21297424"]}, {"Citation": "Hidalgo M., Atluri V. S. R., Nair M. (2015). Drugs of abuse in HIV infection and neurotoxicity. Front. Microbiol. 6:217 10.3389/fmicb.2015.00217", "ArticleIdList": ["10.3389/fmicb.2015.00217", "PMC4371755", "25852673"]}, {"Citation": "Honig L. S., Schupf N., Lee J. H., Tang M. X., Mayeux R. (2006). Shorter telomeres are associated with mortality in those with APOE \ud835\udf164 and dementia. Ann. Neurol. 60 181\u2013187. 10.1002/ana.20894", "ArticleIdList": ["10.1002/ana.20894", "16807921"]}, {"Citation": "Hu K., Kobayashi H., Dong A., Iwasaki S., Yao X. (2000). Antifungal, antimitotic and anti-HIV-1 agents from the roots of Wikstroemia indica. Planta Med. 66 564\u2013567. 10.1055/s-2000-8601", "ArticleIdList": ["10.1055/s-2000-8601", "10985087"]}, {"Citation": "Ishida J., Wang H.-K., Oyama M., Cosentino M. L., Hu C.-Q., Lee K.-H. (2001). Anti-AIDS agents. 46.1 anti-HIV activity of harman, an anti-HIV principle from Symplocos setchuensis, and its Derivatives. J. Nat. Prod. 64 958\u2013960. 10.1021/np0101189", "ArticleIdList": ["10.1021/np0101189", "11473435"]}, {"Citation": "Jaco H., King R. L., Tenywa T., Kyeyune P., Opio A. (2004). Defining minimum standards of practice for incorporating african traditional medicine into HIV/AIDS prevention, care, and support: a regional initiative in eastern and Southern Africa. J. Altern. Complement. Med. 10 905\u2013910. 10.1089/acm.2004.10.905", "ArticleIdList": ["10.1089/acm.2004.10.905", "15650481"]}, {"Citation": "Jiang S., Zhao Q., Debnath A. K. (2002). Peptide and non-peptide HIV fusion inhibitors. Curr. Pharm. Des. 8 563\u2013580. 10.2174/1381612024607180", "ArticleIdList": ["10.2174/1381612024607180", "11945159"]}, {"Citation": "Jain S., Shukla S. D., Sharma K., Bhatnagar M. (2001). Neuroprotective effects of Withania somnifera Dunn. in hippocampal sub-regions of female albino rat. Phytother. Res. 15 544\u2013548. 10.1002/ptr.802", "ArticleIdList": ["10.1002/ptr.802", "11536389"]}, {"Citation": "Kashiwada Y., Nishizawa M., Yamagishi T., Tanaka T., Nonaka G.-I., Cosentino L. M., et al. (1995). Anti-AIDS Agents, 18. sodium and potassium salts of caffeic acid tetramers from Arnebia euchroma as anti-HIV agents. J. Nat. Prod. 58 392\u2013400. 10.1021/np50117a007", "ArticleIdList": ["10.1021/np50117a007", "7775984"]}, {"Citation": "Kashiwada Y., Wang H.-K., Nagao T., Kitanaka S., Yasuda I., Fujioka T., et al. (1998). Anti-AIDS agents. 30. anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids. J. Nat. Prod. 61 1090\u20131095. 10.1021/np9800710", "ArticleIdList": ["10.1021/np9800710", "9748372"]}, {"Citation": "Kaul M. (2009). HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches. Curr. Opin. Neurol. 22 315\u2013320. 10.1097/WCO.0b013e328329cf3c", "ArticleIdList": ["10.1097/WCO.0b013e328329cf3c", "PMC2779773", "19300249"]}, {"Citation": "Kaul M., Garden G. A., Lipton S. A. (2001). Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410 988\u2013994. 10.1038/3507366735073667", "ArticleIdList": ["10.1038/3507366735073667", "11309629"]}, {"Citation": "Kaul M., Lipton S. A. (2006). Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J. Neuroimmune Pharmacol. 1 138\u2013151. 10.1007/s11481-006-9011-9", "ArticleIdList": ["10.1007/s11481-006-9011-9", "18040780"]}, {"Citation": "Kim H. J., Woo E.-R., Shin C.-G., Park H. (1998). A new flavonol glycoside gallate ester from Acer okamotoanum and its inhibitory activity against human immunodeficiency virus-1 (HIV-1) integrase. J. Nat. Prod. 61 145\u2013148. 10.1021/np970171q", "ArticleIdList": ["10.1021/np970171q", "9461665"]}, {"Citation": "Kim S. R., Jeong H. Y., Yang S., Choi S. P., Seo M. Y., Yun Y. K., et al. (2011). Effects of chronic alcohol consumption on expression levels of APP and abeta-producing enzymes. BMB Rep. 44 135\u2013139. 10.5483/BMBRep.2011.44.2.135", "ArticleIdList": ["10.5483/BMBRep.2011.44.2.135", "21345314"]}, {"Citation": "Kitamura K., Honda M., Yoshizaki H., Yamamoto S., Nakane H., Fukushima M., et al. (1998). Baicalin, an inhibitor of HIV-1 production in vitro. Antiviral Res. 37 131\u2013140. 10.1016/S0166-3542(97)00069-7", "ArticleIdList": ["10.1016/S0166-3542(97)00069-7", "9588845"]}, {"Citation": "Kitchen C. M., Kitchen S. G., Dubin J. A., Gottlieb M. S. (2001). Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome. Clin. Infect. Dis. 33 466\u2013472. 10.1086/321900", "ArticleIdList": ["10.1086/321900", "11462181"]}, {"Citation": "Klos M., Van De Venter M., Milne P. J., Traore H. N., Meyer D., Oosthuizen V. (2009). In vitro anti-HIV activity of five selected South African medicinal plant extracts. J. Ethnopharmacol. 124 182\u2013188. 10.1016/j.jep.2009.04.043", "ArticleIdList": ["10.1016/j.jep.2009.04.043", "19409474"]}, {"Citation": "Kraft-Terry S. D., Buch S. J., Fox H. S., Gendelman H. E. (2009). A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron 64 133\u2013145. 10.1016/j.neuron.2009.09.042", "ArticleIdList": ["10.1016/j.neuron.2009.09.042", "PMC2784686", "19840555"]}, {"Citation": "Kuboyama T., Tohda C., Komatsu K. (2005). Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br. J. Pharmacol. 144 961\u2013971. 10.1038/sj.bjp.0706122", "ArticleIdList": ["10.1038/sj.bjp.0706122", "PMC1576076", "15711595"]}, {"Citation": "Kulkarni S. K., Dhir A. (2008). Withania somnifera: an Indian ginseng. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 1093\u20131105. 10.1016/j.pnpbp.2007.09.011", "ArticleIdList": ["10.1016/j.pnpbp.2007.09.011", "17959291"]}, {"Citation": "Kumari G., Singh R. K. (2012). Highly active antiretroviral therapy for treatment of HIV/AIDS patients: current status and future prospects and the Indian scenario. HIV AIDS Rev. 11 5\u201314. 10.1016/j.hivar.2012.02.003", "ArticleIdList": ["10.1016/j.hivar.2012.02.003"]}, {"Citation": "Kurapati K. R., Atluri V. S., Samikkannu T., Nair M. P. (2013). Ashwagandha (Withania somnifera) reverses beta-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). PLoS ONE 8:e77624 10.1371/journal.pone.0077624PONE-D-13-22227", "ArticleIdList": ["10.1371/journal.pone.0077624PONE-D-13-22227", "PMC3797707", "24147038"]}, {"Citation": "Kurapati K. R., Samikkannu T., Atluri V. S., Kaftanovskaya E., Yndart A., Nair M. P. (2014). beta-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide A. PLoS ONE 9:e112818 10.1371/journal.pone.0112818PONE-D-14-30964", "ArticleIdList": ["10.1371/journal.pone.0112818PONE-D-14-30964", "PMC4240587", "25415340"]}, {"Citation": "Lawn S. D., Butera S. T., Folks T. M. (2001). Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin. Microbiol. Rev. 14 753\u2013777. 10.1128/CMR.14.4.753-777.2001", "ArticleIdList": ["10.1128/CMR.14.4.753-777.2001", "PMC89002", "11585784"]}, {"Citation": "Lee T. T.-Y., Kashiwada Y., Huang L., Snider J., Cosentino M., Lee K.-H. (1994). Suksdorfin: an anti-HIV principle from Lomatium suksdorfii, its structure-activity correlation with related coumarins, and synergistic effects with anti-AIDS nucleosides. Bioorg. Med. Chem. 2 1051\u20131056. 10.1016/S0968-0896(00)82054-4", "ArticleIdList": ["10.1016/S0968-0896(00)82054-4", "7773621"]}, {"Citation": "Lee-Huang S., Huang P. L., Huang P. L., Bourinbaiar A. S., Chen H. C., Kung H. F. (1995). Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Proc. Natl. Acad. Sci. U.S.A. 92 8818\u20138822.", "ArticleIdList": ["PMC41058", "7568024"]}, {"Citation": "Li H.-Y., Sun N.-J., Kashiwada Y., Sun L., Snider J. V., Cosentino L. M., et al. (1993). Anti-AIDS agents, 9. Suberosol, a new C31 lanostane-type triterpene and Anti-HIV principle from Polyalthia suberosa. J. Nat. Prod. 56 1130\u20131133. 10.1021/np50097a017", "ArticleIdList": ["10.1021/np50097a017", "8377018"]}, {"Citation": "Li T. (2014). Clinicaltrials.gov, \u2018Study on the Impact of Triptolide Woldifiion on HIV-1 Reservoir In Acute HIV-1 Infection.\u2019 Available at: Clinicaltrials.gov [accessed December 1, 2015]."}, {"Citation": "Lim Y. A., Mei M. C., Kusumoto I. T., Miyashiro H., Hattori M., Gupta M. P., et al. (1997). HIV-1 reverse transcriptase inhibitory principles from Chamaesyce hyssopifolia. Phytother. Res. 11 22\u201327. 10.1002/(SICI)1099-1573(199702)11:1<22::AID-PTR951>3.0.CO;2-3", "ArticleIdList": ["10.1002/(SICI)1099-1573(199702)11:1<22::AID-PTR951>3.0.CO;2-3"]}, {"Citation": "Lin Y.-M., Anderson H., Flavin M. T., Pai Y.-H. S., Mata-Greenwood E., Pengsuparp T., et al. (1997). In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora. J. Nat. Prod. 60 884\u2013888. 10.1021/np9700275", "ArticleIdList": ["10.1021/np9700275", "9322359"]}, {"Citation": "Lindl K. A., Marks D. R., Kolson D. L., Jordan-Sciutto K. L. (2010). HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J. Neuroimmune Pharmacol. 5 294\u2013309. 10.1007/s11481-010-9205-z", "ArticleIdList": ["10.1007/s11481-010-9205-z", "PMC2914283", "20396973"]}, {"Citation": "Liu J.-S., Li L. (1995). Kadsulignans L-N, three dibenzocyclooctadiene lignans from Kadsura coccinea. Phytochemistry 38 241\u2013245. 10.1016/0031-9422(94)00557-A", "ArticleIdList": ["10.1016/0031-9422(94)00557-A"]}, {"Citation": "Loya S., Rudi A., Kashman Y., Hizi A. (1999). Polycitone A, a novel and potent general inhibitor of retroviral reverse transcriptases and cellular DNA polymerases. Biochem. J. 344 85\u201392. 10.1042/bj3440085", "ArticleIdList": ["10.1042/bj3440085", "PMC1220617", "10548537"]}, {"Citation": "Lu W. (2013). Clinicaltrials.gov, \u2018Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-Responders (CACTrip12).\u2019 Available at: Clinicaltrials.gov [accessed December 1, 2015]."}, {"Citation": "L\u00fcscher-Mattli M. (2000). Polyanions\u2013a lost chance in the fight against HIV and other virus diseases? Antivir. Chem. Chemother. 11 249\u2013259. 10.1177/095632020001100401", "ArticleIdList": ["10.1177/095632020001100401", "10950387"]}, {"Citation": "Mahmood N., Piacente S., Burke A., Khan A. I., Pizza C. (1997). Constituents of Cuscuto reflexa are anti-HIV Agents. Antivir. Chem. Chemother. 8 70\u201374. 10.1177/095632029700800108", "ArticleIdList": ["10.1177/095632029700800108"]}, {"Citation": "Malan-Muller S., Hemmings S. M., Spies G., Kidd M., Fennema-Notestine C., Seedat S. (2013). Shorter telomere length - a potential susceptibility factor for HIV-associated neurocognitive impairments in South African women [corrected]. PLoS ONE 8:e58351 10.1371/journal.pone.0058351PONE-D-12-29635", "ArticleIdList": ["10.1371/journal.pone.0058351PONE-D-12-29635", "PMC3589394", "23472184"]}, {"Citation": "Mann D. A., Frankel A. D. (1991). Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10 1733\u20131739.", "ArticleIdList": ["PMC452844", "2050110"]}, {"Citation": "Martin-Ruiz C., Dickinson H. O., Keys B., Rowan E., Kenny R. A., Von Zglinicki T. (2006). Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann. Neurol. 60 174\u2013180. 10.1002/ana.20869", "ArticleIdList": ["10.1002/ana.20869", "16685698"]}, {"Citation": "McArthur J. C., Haughey N., Gartner S., Conant K., Pardo C., Nath A., et al. (2003). Human immunodeficiency virus-associated dementia: an evolving disease. J. Neurovirol. 9 205\u2013221. 10.1080/135502803901941094J811MK1R26FL3NR", "ArticleIdList": ["10.1080/135502803901941094J811MK1R26FL3NR", "12707851"]}, {"Citation": "McArthur J. C., Mcdermott M. P., Mcclernon D., St Hillaire C., Conant K., Marder K., et al. (2004). Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch. Neurol. 61 1687\u20131696. 10.1001/archneur.61.11.1687", "ArticleIdList": ["10.1001/archneur.61.11.1687", "15534180"]}, {"Citation": "McArthur J. C., Steiner J., Sacktor N., Nath A. (2010). Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann. Neurol. 67 699\u2013714. 10.1002/ana.22053", "ArticleIdList": ["10.1002/ana.22053", "20517932"]}, {"Citation": "McCormick J. L., Mckee T. C., Cardellina J. H., Boyd M. R. (1996). HIV inhibitory natural products. 26. Quinoline alkaloids from Euodia roxburghiana. J. Nat. Prod. 59 469\u2013471. 10.1021/np960250m", "ArticleIdList": ["10.1021/np960250m", "8778237"]}, {"Citation": "Meragelman K. M., Mckee T. C., Boyd M. R. (2001). Anti-HIV prenylated flavonoids from Monotes africanus1. J. Nat. Prod. 64 546\u2013548. 10.1021/np0005457", "ArticleIdList": ["10.1021/np0005457", "11325248"]}, {"Citation": "Min B. S., Jung H. J., Lee J. S., Kim Y. H., Bok S. H., Ma C. M., et al. (1999). Inhibitory effect of triterpenes from Crataegus pinatifida on HIV-I protease. Planta Med. 65 374\u2013375. 10.1055/s-2006-960792", "ArticleIdList": ["10.1055/s-2006-960792", "10364847"]}, {"Citation": "Min B. S., Miyashiro H., Hattori M. (2002). Inhibitory effects of quinones on RNase H activity associated with HIV-1 reverse transcriptase. Phytother. Res. 16(Suppl. 1) S57\u2013S62. 10.1002/ptr.808", "ArticleIdList": ["10.1002/ptr.808", "11933141"]}, {"Citation": "Mishra L. C., Singh B. B., Dagenais S. (2000). Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern. Med. Rev. 5 334\u2013346.", "ArticleIdList": ["10956379"]}, {"Citation": "Mohri H., Perelson A. S., Tung K., Ribeiro R. M., Ramratnam B., Markowitz M., et al. (2001). Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J. Exp. Med. 194 1277\u20131288. 10.1084/jem.194.9.1277", "ArticleIdList": ["10.1084/jem.194.9.1277", "PMC2195973", "11696593"]}, {"Citation": "Molto J. (2010). Clinicaltrials.gov, \u2018Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir.\u2019 Available at: Clinicaltrials.gov [accessed December 1, 2015]."}, {"Citation": "Munoz-Moreno J. A., Fumaz C. R., Ferrer M. J., Prats A., Negredo E., Garolera M., et al. (2008). Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients. AIDS Res. Hum. Retrovir. 24 1301\u20131307. 10.1089/aid.2007.0310", "ArticleIdList": ["10.1089/aid.2007.0310", "18844464"]}, {"Citation": "Murray M. T., Pizzorno J. E. (1999). Textbook of Natural Medicine. London: Churchill Livingstone."}, {"Citation": "Murray S. M., Down C. M., Boulware D. R., Stauffer W. M., Cavert W. P., Schacker T. W., et al. (2010). Reduction of immune activation with chloroquine therapy during chronic HIV infection. J. Virol. 84 12082\u201312086. 10.1128/JVI.01466-10", "ArticleIdList": ["10.1128/JVI.01466-10", "PMC2977889", "20844049"]}, {"Citation": "Nair M. P. N., Saiyed Z. M., Nair N., Gandhi N. H., Rodriguez J. W., Boukli N., et al. (2009). Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J. Neuroimmune Pharmacol. 4 129\u2013139. 10.1007/s11481-008-9128-0", "ArticleIdList": ["10.1007/s11481-008-9128-0", "PMC3764920", "18958626"]}, {"Citation": "Nair M. P. N., Schwartz S. A., Mahajan S. D., Tsiao C., Chawda R. P., Whitney R., et al. (2004). Drug abuse and neuropathogenesis of HIV infection: role of DC-SIGN and IDO. J. Neuroimmunol. 157 56\u201360. 10.1016/j.jneuroim.2004.08.040", "ArticleIdList": ["10.1016/j.jneuroim.2004.08.040", "15579280"]}, {"Citation": "Nath A., Schiess N., Venkatesan A., Rumbaugh J., Sacktor N., Mcarthur J. (2008). Evolution of HIV dementia with HIV infection. Int. Rev. Psychiatry 20 25\u201331. 10.1080/09540260701861930", "ArticleIdList": ["10.1080/09540260701861930", "18240060"]}, {"Citation": "Nottet H. S., Gendelman H. E. (1995). Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol. Today 16 441\u2013448. 10.1016/0167-5699(95)80022-0", "ArticleIdList": ["10.1016/0167-5699(95)80022-0", "7546209"]}, {"Citation": "Ogata T., Higuchi H., Mochida S., Matsumoto H., Kato A., Endo T., et al. (1992). HIV-1 reverse transcriptase inhibitor from Phyllanthus niruri. AIDS Res. Hum. Retrovir. 8 1937\u20131944. 10.1089/aid.1992.8.1937", "ArticleIdList": ["10.1089/aid.1992.8.1937", "1283310"]}, {"Citation": "Ohtake N., Nakai Y., Yamamoto M., Sakakibara I., Takeda S., Amagaya S., et al. (2004). Separation and isolation methods for analysis of the active principles of Sho-saiko-to (SST) oriental medicine. J. Chromatogr. B 812 135\u2013148. 10.1016/j.jchromb.2004.06.051", "ArticleIdList": ["10.1016/j.jchromb.2004.06.051", "PMC7105231", "15556493"]}, {"Citation": "Orhan D. D., Ozcelik B., Ozgen S., Ergun F. (2010). Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiol. Res. 165 496\u2013504. 10.1016/j.micres.2009.09.002", "ArticleIdList": ["10.1016/j.micres.2009.09.002", "19840899"]}, {"Citation": "Panossian L. A., Porter V. R., Valenzuela H. F., Zhu X., Reback E., Masterman D., et al. (2003). Telomere shortening in T cells correlates with Alzheimer\u2019s disease status. Neurobiol. Aging 24 77\u201384. 10.1016/S0197-4580(02)00043-X", "ArticleIdList": ["10.1016/S0197-4580(02)00043-X", "12493553"]}, {"Citation": "Park J. C., Hur J. M., Park J. G., Hatano T., Yoshida T., Miyashiro H., et al. (2002). Inhibitory effects of Korean medicinal plants and camelliatannin H from Camellia japonica on human immunodeficiency virus type 1 protease. Phytother. Res. 16 422\u2013426. 10.1002/ptr.919", "ArticleIdList": ["10.1002/ptr.919", "12203260"]}, {"Citation": "Pathai S., Lawn S. D., Gilbert C. E., Mcguinness D., Mcglynn L., Weiss H. A., et al. (2013). Accelerated biological ageing in HIV-infected individuals in South Africa: a case-control study. AIDS 27 2375\u20132384. 10.1097/QAD.0b013e328363bf7f", "ArticleIdList": ["10.1097/QAD.0b013e328363bf7f", "PMC3805356", "23751258"]}, {"Citation": "Paul R., Flanigan T. P., Tashima K., Cohen R., Lawrence J., Alt E., et al. (2005). Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus. J. Neuropsychiatry Clin. Neurosci. 17 114\u2013118. 10.1176/jnp.17.1.114", "ArticleIdList": ["10.1176/jnp.17.1.114", "15746491"]}, {"Citation": "Petrovas C., Casazza J. P., Brenchley J. M., Price D. A., Gostick E., Adams W. C., et al. (2006). PD-1 is a regulator of virus-specific CD8(+) T cell survival in HIV infection. J. Exp. Med. 203 2281\u20132292. 10.1084/jem.20061496", "ArticleIdList": ["10.1084/jem.20061496", "PMC2118095", "16954372"]}, {"Citation": "Piconi S., Parisotto S., Rizzardini G., Passerini S., Terzi R., Argenteri B., et al. (2011). Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders. Blood 118 3263\u20133272. 10.1182/blood-2011-01-329060", "ArticleIdList": ["10.1182/blood-2011-01-329060", "21576701"]}, {"Citation": "Ptak R. G. (2002). HIV-1 regulatory proteins: targets for novel drug development. Expert Opin. Investig. Drugs 11 1099\u20131115. 10.1517/13543784.11.8.1099", "ArticleIdList": ["10.1517/13543784.11.8.1099", "12150704"]}, {"Citation": "Rambaut A., Robertson D. L., Pybus O. G., Peeters M., Holmes E. C. (2001). Human immunodeficiency virus: phylogeny and the origin of HIV-1. Nature 410 1047\u20131048. 10.1038/35074179", "ArticleIdList": ["10.1038/35074179", "11323659"]}, {"Citation": "Reddy P. V., Pilakka-Kanthikeel S., Saxena S. K., Saiyed Z., Nair M. P. (2012). Interactive effects of morphine on HIV infection: role in HIV-associated neurocognitive disorder. AIDS Res. Treat. 2012:953678 10.1155/2012/953678", "ArticleIdList": ["10.1155/2012/953678", "PMC3362817", "22666564"]}, {"Citation": "Resh M. D. (2005). Intracellular trafficking of HIV-1 Gag: how Gag interacts with cell membranes and makes viral particles. AIDS Rev. 7 84\u201391.", "ArticleIdList": ["16092502"]}, {"Citation": "Rimando A. M., Pezzuto J. M., Farnsworth N. R., Santisuk T., Reutrakul V., Kawanishi K. (1994). New lignans from Anogeissus acuminata with HIV-1 reverse transcriptase inhibitory activity. J. Nat. Prod. 57 896\u2013904. 10.1021/np50109a004", "ArticleIdList": ["10.1021/np50109a004", "7525878"]}, {"Citation": "Robertson K. R., Smurzynski M., Parsons T. D., Wu K., Bosch R. J., Wu J., et al. (2007). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21 1915\u20131921. 10.1097/QAD.0b013e32828e4e2700002030-200709120-00011", "ArticleIdList": ["10.1097/QAD.0b013e32828e4e2700002030-200709120-00011", "17721099"]}, {"Citation": "Rodriguez B., Sethi A. K., Cheruvu V. K., Mackay W., Bosch R. J., Kitahata M., et al. (2006). Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 296 1498\u20131506. 10.1001/jama.296.12.1498", "ArticleIdList": ["10.1001/jama.296.12.1498", "17003398"]}, {"Citation": "Roth G. N., Chandra A., Nair M. G. (1998). Novel bioactivities of Curcuma longa constituents. J. Nat. Prod. 61 542\u2013545. 10.1021/np970459f", "ArticleIdList": ["10.1021/np970459f", "9584408"]}, {"Citation": "Roy U., Atluri V. S., Agudelo M., Yndart A., Huang Z., Nair M. (2015). DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine. Front. Microbiol. 6:749 10.3389/fmicb.2015.00749", "ArticleIdList": ["10.3389/fmicb.2015.00749", "PMC4517050", "26284039"]}, {"Citation": "Rukachaisirikul V., Pailee P., Hiranrat A., Tuchinda P., Yoosook C., Kasisit J., et al. (2003). Anti-HIV-1 protostane triterpenes and digeranylbenzophenone from trunk bark and stems of Garcinia speciosa. Planta Med. 69 1141\u20131146. 10.1055/s-2003-818006", "ArticleIdList": ["10.1055/s-2003-818006", "14750032"]}, {"Citation": "Sacktor N., Lyles R. H., Skolasky R., Kleeberger C., Selnes O. A., Miller E. N., et al. (2001). HIV-associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990-1998. Neurology 56 257\u2013260. 10.1212/WNL.56.2.257", "ArticleIdList": ["10.1212/WNL.56.2.257", "11160967"]}, {"Citation": "Sacktor N., Mcdermott M., Marder K., Schifitto G., Selnes O., Mcarthur J., et al. (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. J. Neurovirol. 8 136\u2013142. 10.1080/13550280290049615", "ArticleIdList": ["10.1080/13550280290049615", "11935465"]}, {"Citation": "Sagar V., Pilakka-Kanthikeel S., Atluri V. S. R., Ding H., Arias A. Y., Jayant R. D., et al. (2015). Therapeutical neurotargeting via magnetic nanocarrier: implications to opiate-induced neuropathogenesis and NeuroAIDS. J. Biomed. Nanotechnol. 11 1722\u20131733. 10.1166/jbn.2015.2108", "ArticleIdList": ["10.1166/jbn.2015.2108", "PMC4624254", "26502636"]}, {"Citation": "Sakurai N., Wu J. H., Sashida Y., Mimaki Y., Nikaido T., Koike K., et al. (2004). Anti-AIDS agents. Part 57: actein, an anti-HIV principle from the rhizome of Cimicifuga racemosa (black cohosh), and the anti-HIV activity of related saponins. Bioorg Med. Chem. Lett. 14 1329\u20131332. 10.1016/j.bmcl.2003.12.035S0960894X03013222", "ArticleIdList": ["10.1016/j.bmcl.2003.12.035S0960894X03013222", "14980692"]}, {"Citation": "Samikkannu T., Ranjith D., Rao K. V., Atluri V. S., Pimentel E., El-Hage N., et al. (2015a). HIV-1 gp120 and morphine induced oxidative stress: role in cell cycle regulation. Front. Microbiol. 6:614 10.3389/fmicb.2015.00614", "ArticleIdList": ["10.3389/fmicb.2015.00614", "PMC4477635", "26157430"]}, {"Citation": "Samikkannu T., Rao K. V., Salam A. A., Atluri V. S., Kaftanovskaya E. M., Agudelo M., et al. (2015b). HIV subtypes B and C gp120 and methamphetamine interaction: dopaminergic system implicates differential neuronal toxicity. Sci. Rep. 5:11130 10.1038/srep11130", "ArticleIdList": ["10.1038/srep11130", "PMC4460916", "26057350"]}, {"Citation": "Samikkannu T., Rao K. K., Gandhi N., Saxena S., Nair M. N. (2010). Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: implications for neuroAIDS. J. Neurovirol. 16 255\u2013263. 10.3109/13550284.2010.497809", "ArticleIdList": ["10.3109/13550284.2010.497809", "20602605"]}, {"Citation": "Sankar S. R., Manivasagam T., Krishnamurti A., Ramanathan M. (2007). The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical variables. Cell Mol. Biol. Lett. 12 473\u2013481. 10.2478/s11658-007-0015-0", "ArticleIdList": ["10.2478/s11658-007-0015-0", "PMC6275882", "17415533"]}, {"Citation": "Saxena S. K., Tiwari S., Nair M. P. (2012). A global perspective on HIV/AIDS. Science 337:798 10.1126/science.337.6096.798", "ArticleIdList": ["10.1126/science.337.6096.798", "22903995"]}, {"Citation": "Schader S. M., Wainberg M. A. (2011). Insights into HIV-1 pathogenesis through drug discovery: 30 years of basic research and concerns for the future. HIV AIDS Rev. 10 91\u201398. 10.1016/j.hivar.2011.09.003", "ArticleIdList": ["10.1016/j.hivar.2011.09.003"]}, {"Citation": "Schulz V. (2006). Safety of St. John\u2019s Wort extract compared to synthetic antidepressants. Phytomedicine 13 199\u2013204. 10.1016/j.phymed.2005.07.005", "ArticleIdList": ["10.1016/j.phymed.2005.07.005", "16428030"]}, {"Citation": "Sebit M. B., Chandiwana S. K., Latif A. S., Gomo E., Acuda S. W., Makoni F., et al. (2000). Quality of life evaluation in patients with HIV-I infection: the impact of traditional medicine in Zimbabwe. Cent. Afr. J. Med. 46 208\u2013213.", "ArticleIdList": ["11317592"]}, {"Citation": "Sehgal N., Gupta A., Valli R. K., Joshi S. D., Mills J. T., Hamel E., et al. (2012). Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc. Natl. Acad. Sci. U.S.A. 109 3510\u20133515.", "ArticleIdList": ["PMC3295277", "22308347"]}, {"Citation": "Sharer L. R. (1992). Pathology of HIV-1 infection of the central nervous system. A review. J. Neuropathol. Exp. Neurol. 51 3\u201311. 10.1097/00005072-199201000-00002", "ArticleIdList": ["10.1097/00005072-199201000-00002", "1740672"]}, {"Citation": "Short R. V. (2006). New ways of preventing HIV infection: thinking simply, simply thinking. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361 811\u2013820. 10.1098/rstb.2005.1781", "ArticleIdList": ["10.1098/rstb.2005.1781", "PMC1609406", "16627296"]}, {"Citation": "Simioni S., Cavassini M., Annoni J. M., Rimbault Abraham A., Bourquin I., Schiffer V., et al. (2010). Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24 1243\u20131250. 10.1097/QAD.0b013e3283354a7b", "ArticleIdList": ["10.1097/QAD.0b013e3283354a7b", "19996937"]}, {"Citation": "Soontornniyomkij V., Moore D. J., Gouaux B., Soontornniyomkij B., Tatro E. T., Umlauf A., et al. (2012). Cerebral beta-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE epsilon4 carriers. AIDS 26 2327\u20132335. 10.1097/QAD.0b013e32835a117c", "ArticleIdList": ["10.1097/QAD.0b013e32835a117c", "PMC3576852", "23018443"]}, {"Citation": "Sun Y., Huang P. L., Li J. J., Huang Y. Q., Zhang L., Huang P. L., et al. (2001). Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi\u2019s sarcoma-associated virus. Biochem. Biophys. Res. Commun. 287 983\u2013994. 10.1006/bbrc.2001.5689", "ArticleIdList": ["10.1006/bbrc.2001.5689", "11573962"]}, {"Citation": "Tan G. T., Pezzuto J. M., Kinghorn A. D., Hughes S. H. (1991). Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. J. Nat. Prod. 54 143\u2013154. 10.1021/np50073a012", "ArticleIdList": ["10.1021/np50073a012", "1710653"]}, {"Citation": "Tozzi V., Balestra P., Galgani S., Narciso P., Ferri F., Sebastiani G., et al. (1999). Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS 13 1889\u20131897. 10.1097/00002030-199910010-00011", "ArticleIdList": ["10.1097/00002030-199910010-00011", "10513647"]}, {"Citation": "Uchiumi F., Hatano T., Ito H., Yoshida T., Tanuma S. (2003). Transcriptional suppression of the HIV promoter by natural compounds. Antiviral Res. 58 89\u201398. 10.1016/S0166-3542(02)00186-9", "ArticleIdList": ["10.1016/S0166-3542(02)00186-9", "12719011"]}, {"Citation": "Uchiumi F., Maruta H., Inoue J., Yamamoto T., Tanuma S. (1996). Inhibitory effect of tannic acid on human immunodeficiency virus promoter activity induced by 12-O-tetra decanoylphorbol-13-acetate in Jurkat T-cells. Biochem. Biophys. Res. Commun. 220 411\u2013417. 10.1006/bbrc.1996.0419", "ArticleIdList": ["10.1006/bbrc.1996.0419", "8645319"]}, {"Citation": "UNAIDS (2010). UNAIDS Report on the Global AIDS Epidemic 2010. Geneva: UNAIDS"}, {"Citation": "UNAIDS (2011). World AIDS Day Report 2011. Geneva: UNAIDS"}, {"Citation": "Valdes A. M., Deary I. J., Gardner J., Kimura M., Lu X., Spector T. D., et al. (2008). Leukocyte telomere length is associated with cognitive performance in healthy women. Neurobiol. Aging 31 986\u2013992. 10.1016/j.neurobiolaging.2008.07.012", "ArticleIdList": ["10.1016/j.neurobiolaging.2008.07.012", "PMC2876308", "18718693"]}, {"Citation": "Valenti W. M. (2001). HAART is cost-effective and improves outcomes. AIDS Read. 11 260\u2013262.", "ArticleIdList": ["11392694"]}, {"Citation": "Vermani K., Garg S. (2002). Herbal medicines for sexually transmitted diseases and AIDS. J. Ethnopharmacol. 80 49\u201366. 10.1016/S0378-8741(02)00009-0", "ArticleIdList": ["10.1016/S0378-8741(02)00009-0", "11891087"]}, {"Citation": "Vitiello B., Goodkin K., Ashtana D., Shapshak P., Atkinson J. H., Heseltine P. N., et al. (2007). HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people. AIDS 21 1415\u20131422. 10.1097/QAD.0b013e328220e71a00002030-200707110-00004", "ArticleIdList": ["10.1097/QAD.0b013e328220e71a00002030-200707110-00004", "17589187"]}, {"Citation": "Vlietinck A. J., De Bruyne T., Apers S., Pieters L. A. (1998). Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med. 64 97\u2013109. 10.1055/s-2006-957384", "ArticleIdList": ["10.1055/s-2006-957384", "9525100"]}, {"Citation": "von Zglinicki T., Serra V., Lorenz M., Saretzki G., Lenzen-Grossimlighaus R., Gessner R., et al. (2000). Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab. Invest. 80 1739\u20131747. 10.1038/labinvest.3780184", "ArticleIdList": ["10.1038/labinvest.3780184", "11092534"]}, {"Citation": "Wang J. (2009a). Clinicaltrials.gov, \u2018Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) On Immune Reconstitution of HIV Patients.\u2019 Available at: Clinicaltrials.gov [accessed December 1, 2015]."}, {"Citation": "Wang J. (2009b). Clinicaltrials.gov, \u2018Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART).\u2019 Available at: Clinicaltrials.gov [accessed December 1, 2015]."}, {"Citation": "Wang J. (2009c). Clinicaltrials.gov, \u2018The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS Patients.\u2019 Available at: Clinicaltrials.gov [accessed December 1, 2015]."}, {"Citation": "Wang J. N., Hou C. Y., Liu Y. L., Lin L. Z., Gil R. R., Cordell G. A. (1994). Swertifrancheside, an HIV-reverse transcriptase inhibitor and the first flavone-xanthone dimer, from Swertia franchetiana. J. Nat. Prod. 57 211\u2013217. 10.1021/np50104a003", "ArticleIdList": ["10.1021/np50104a003", "7513747"]}, {"Citation": "Wang Q., Ding Z.-H., Liu J.-K., Zheng Y.-T. (2004). Xanthohumol, a novel anti-HIV-1 agent purified from Hops Humulus lupulus. Antiviral Res. 64 189\u2013194. 10.1016/j.antiviral.2004.08.005", "ArticleIdList": ["10.1016/j.antiviral.2004.08.005", "15550272"]}, {"Citation": "Wayengera M. (2011). Targeting persistent HIV infection: where and how, if possible? HIV AIDS Rev. 10 1\u20138. 10.1016/j.hivar.2011.01.002", "ArticleIdList": ["10.1016/j.hivar.2011.01.002"]}, {"Citation": "Witvrouw M., De Clercq E. (1997). Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen. Pharmacol. 29 497\u2013511. 10.1016/S0306-3623(96)00563-0", "ArticleIdList": ["10.1016/S0306-3623(96)00563-0", "9352294"]}, {"Citation": "World Health Organization [WHO] (1989a). In vitro screening of traditional medicines for anti-HIV activity: memorandum from a WHO meeting. Bull. World Health Organ. 67 613\u2013618.", "ArticleIdList": ["PMC2491302", "2633879"]}, {"Citation": "World Health Organization [WHO] (1989b). Report of a WHO Informal Consultation on Traditional Medicine and AIDS: In Vitro Screening for Anti-HIV Activity, Geneva, 6-8 February 1989. Geneva: World Health Organization."}, {"Citation": "World Health Organization [WHO] (2002). WHO Traditional Medicine Strategy 2002-2005. Geneva: World Health Organization; 1\u201361."}, {"Citation": "Xu H. X., Wan M., Dong H., But P. P., Foo L. Y. (2000). Inhibitory activity of flavonoids and tannins against HIV-1 protease. Biol. Pharm. Bull. 23 1072\u20131076. 10.1248/bpb.23.1072", "ArticleIdList": ["10.1248/bpb.23.1072", "10993207"]}, {"Citation": "Xu H.-X., Zeng F.-Q., Wan M., Sim K.-Y. (1996). Anti-HIV triterpene acids from Geum japonicum. J. Nat. Prod. 59 643\u2013645. 10.1021/np960165e", "ArticleIdList": ["10.1021/np960165e", "8759159"]}, {"Citation": "Xu J., Ikezu T. (2009). The comorbidity of HIV-associated neurocognitive disorders and Alzheimer\u2019s disease: a foreseeable medical challenge in post-HAART era. J. Neuroimmune Pharmacol. 4 200\u2013212. 10.1007/s11481-008-9136-0", "ArticleIdList": ["10.1007/s11481-008-9136-0", "PMC2682636", "19016329"]}, {"Citation": "Yaffe K., Lindquist K., Kluse M., Cawthon R., Harris T., Hsueh W.-C., et al. (2009). Telomere length and cognitive function in community-dwelling elders: findings from the Health ABC Study. Neurobiol. Aging 32 2055\u20132060. 10.1016/j.neurobiolaging.2009.12.006", "ArticleIdList": ["10.1016/j.neurobiolaging.2009.12.006", "PMC2916948", "20031273"]}, {"Citation": "Yamaguchi K., Honda M., Ikigai H., Hara Y., Shimamura T. (2002). Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Res. 53 19\u201334. 10.1016/S0166-3542(01)00189-9", "ArticleIdList": ["10.1016/S0166-3542(01)00189-9", "11684313"]}, {"Citation": "Yao-Haur K., Li-Ming Yang K. (1997). Antitumour and anti-AIDS triterpenes from Celastrus hindsii. Phytochemistry 44 1275\u20131281. 10.1016/S0031-9422(96)00719-4", "ArticleIdList": ["10.1016/S0031-9422(96)00719-4", "9115698"]}, {"Citation": "Yu D., Suzuki M., Xie L., Morris-Natschke S. L., Lee K.-H. (2003). Recent progress in the development of coumarin derivatives as potent anti-HIV agents. Med. Res. Rev. 23 322\u2013345. 10.1002/med.10034", "ArticleIdList": ["10.1002/med.10034", "12647313"]}, {"Citation": "Zanet D. L., Thorne A., Singer J., Maan E. J., Sattha B., Le Campion A., et al. (2012). Association between short leukocyte telomere length and HIV infection in a cohort study: no evidence of a relationship with antiretroviral therapy. Clin. Infect. Dis. 58 1322\u20131332. 10.1093/cid/ciu051", "ArticleIdList": ["10.1093/cid/ciu051", "24457340"]}, {"Citation": "Zhou P., Takaishi Y., Duan H., Chen B., Honda G., Itoh M., et al. (2000). Coumarins and bicoumarin from Ferula sumbul: anti-HIV activity and inhibition of cytokine release. Phytochemistry 53 689\u2013697. 10.1016/S0031-9422(99)00554-3", "ArticleIdList": ["10.1016/S0031-9422(99)00554-3", "10746882"]}, {"Citation": "Zou W., Kim B. O., Zhou B. Y., Liu Y., Messing A., He J. J. (2007). Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein. Am. J. Pathol. 171 1923\u20131935. 10.2353/ajpath.2007.070333", "ArticleIdList": ["10.2353/ajpath.2007.070333", "PMC2111115", "18055541"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "4", "Day": "12"}, {"Year": "2015", "Month": "12", "Day": "3"}, {"Year": "2016", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "1", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "1", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2016", "Month": "1", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["26793166", "PMC4709506", "10.3389/fmicb.2015.01444"]}}], "PubmedBookArticle": []}